Search - tctmd.com

Displaying 901 - 920 of 2439

Sort: Relevancy | Date

Presentation TCT 2017

Case #5: How to Implant Bioresorbable Scaffolds in Calcified Lesions (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta, Antonio Colombo

October 30, 2017

Presentation TCT 2017

Drug-Coated Balloons in the Lower Extremity: Impact and Lessons Learned

Presenter: Michael Guiry, Julie Logan, Craig M. Walker

October 30, 2017

Presentation TCT 2017

Case #4: How to Use Imaging During Bioresorbable Scaffold Implantation (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta, Daniel Chamie

October 30, 2017

Presentation TCT 2017

Case #3: How to Implant Bioresorbable Scaffolds in CTO (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta, Alessio G La Manna

October 30, 2017

Presentation TCT 2017

DARE: A Randomized Trial of a Drug-Eluting Balloon vs a Metallic DES in Patients With Coronary Artery In-Stent Restenosis

Presenter: Fernando Alfonso, Jose P.S. Henriques

October 30, 2017

Presentation TCT 2017

The Alphabet of Peripheral Vascular Devices: BMS, DES, PTFE, BVS, and Future Scaffolds

Presenter: Michael Guiry, Julie Logan

October 30, 2017

Presentation TCT 2017

Case #2: How to Implant Bioresorbable Scaffolds in Bifurcation Lesions (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta, Javier Suárez de Lezo

October 30, 2017

Presentation TCT 2017

HARMONEE: A Randomized Trial of a Bioabsorbable Polymer-Based DES With a Luminal CD34+ Antibody Coating vs a Durable Polymer-Based DES in Patients With Coronary Artery Disease

Presenter: Fernando Alfonso, Mitchell W. Krucoff

October 30, 2017

Presentation TCT 2017

Case #1: How to Implant Bioresorbable Scaffolds in STEMI (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta, Petr Tousek

October 30, 2017

Presentation TCT 2017

Predicting The Future: Will the ABSORB III/IV Ten-Year Results Change How We Currently View Bioresorbable Vascular Scaffolds?

Presenter: C. Michael Gibson, Stephan Windecker, Stephan Achenbach

October 30, 2017

Presentation TCT 2017

What Is the Future of Bioabsorbable Scaffolds?

Presenter: Anibal A. Damonte, Alejandro O. Palacios, Patrick W. Serruys

October 29, 2017

Presentation TCT 2017

Next Generation BRS Platforms

Presenter: Gary S. Mintz, Seung-Jung Park, Alan C. Yeung

October 29, 2017

Presentation TCT 2017

Bioresorbable Scaffolds and Outcomes 2017

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Jochen Wöhrle

October 29, 2017

Presentation TCT 2017

BRS Randomized Trials: What Was Wrong the Lesions, the Scaffold, or the Technique?

Presenter: Gary S. Mintz, Seung-Jung Park

October 29, 2017

Presentation TCT 2017

Lessons from the ABSORB Clinical Program for the Future

Presenter: Gary S. Mintz, Seung-Jung Park, Patrick W. Serruys

October 29, 2017

Presentation TCT 2017

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Binita Shah

October 29, 2017

Presentation TCT 2017

Drug-Eluting Stent Platforms and Outcomes 2017

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Gennaro Sardella

October 29, 2017

Presentation TCT 2017

Bioresorbable Scaffolds Are Here to Stay!

Presenter: Antonio Colombo, Stephen G. Ellis, Ron Waksman

October 29, 2017

Presentation TCT 2017

Case Presentation: DCB in a De Novo Lesion

Presenter: Roxana Mehran, Bo Xu, Jun Jiang

October 29, 2017

Presentation TCT 2017

Current Practice and Perspectives on DCB in China

Presenter: Roxana Mehran, Bo Xu, YunDai Chen

October 29, 2017

Advertisement

Case #5: How to Implant Bioresorbable Scaffolds in Calcified Lesions (With Discussion)

Drug-Coated Balloons in the Lower Extremity: Impact and Lessons Learned

Case #4: How to Use Imaging During Bioresorbable Scaffold Implantation (With Discussion)

Case #3: How to Implant Bioresorbable Scaffolds in CTO (With Discussion)

DARE: A Randomized Trial of a Drug-Eluting Balloon vs a Metallic DES in Patients With Coronary Artery In-Stent Restenosis

The Alphabet of Peripheral Vascular Devices: BMS, DES, PTFE, BVS, and Future Scaffolds

Case #2: How to Implant Bioresorbable Scaffolds in Bifurcation Lesions (With Discussion)

HARMONEE: A Randomized Trial of a Bioabsorbable Polymer-Based DES With a Luminal CD34+ Antibody Coating vs a Durable Polymer-Based DES in Patients With Coronary Artery Disease

Case #1: How to Implant Bioresorbable Scaffolds in STEMI (With Discussion)

Predicting The Future: Will the ABSORB III/IV Ten-Year Results Change How We Currently View Bioresorbable Vascular Scaffolds?

What Is the Future of Bioabsorbable Scaffolds?

Next Generation BRS Platforms

Bioresorbable Scaffolds and Outcomes 2017

BRS Randomized Trials: What Was Wrong the Lesions, the Scaffold, or the Technique?

Lessons from the ABSORB Clinical Program for the Future

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Drug-Eluting Stent Platforms and Outcomes 2017

Bioresorbable Scaffolds Are Here to Stay!

Case Presentation: DCB in a De Novo Lesion

Current Practice and Perspectives on DCB in China

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content